MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges

Author(s): Shalaby T, Grotzer MA

Abstract

The MYC family plays essential roles during brain development and their oncogenic deregulation is implicated in the formation of embryonal neural tumors such as medulloblastomas (MB) and neuroblastoma (NB). Amplification of the MYCN is the predominant marker for aggressive NB and correlates with poor prognosis, while c-MYC overexpression is a defining feature of MB subgroups inflected with aggressive biological behavior and increased likelihood of metastasis. Not surprisingly MYC has emerged as an attractive target for pediatric neural cancer therapy. However despite three decades of intensive research in MYC biology and an impressive number of 30,000 publications, inhibition of MYC as therapeutic strategy remains an elusive goal in cancer medicine. This review discusses the potential and challenges of targeting the oncogenic effects of MYC as therapeutic strategy for MYC over-expressing embryonal neural tumors where current therapies are inadequate.

Similar Articles

Gene function analysis in osteosarcoma based on microarray gene expression profiling

Author(s): Zhao L, Zhang J, Tan H, Wang W, Liu Y, et al.

Kras G12D induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells

Author(s): Diersch S, Wirth M, Schneewels C, Jors S, Geisler F, et al.

Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer

Author(s): Al-Hujaily EM, Tang Y, Yao DS, Carmona E, Garson K, et al.

Stopping the Clock with MYC

Author(s): Lau AN, Vander Heiden MG

Pluripotency transcription factors in lung cancer-a review

Author(s): Saawek S, Szmyt K, Fularz M, Dziudzia J, Boruczkowski M, et al.

Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer

Author(s): Patel K, Chowdhury N, Doddapaneni R, Boakye CH, Godugu C, et al.

Angiosarcoma Arising in Chronic Expanding Hematoma: Five Cases of an Underrecognized Association

Author(s): Lon CEB, Riddle ND, Lackman RD, Evenski AJ, Brooks JS

The microRNA-212/132 cluster regulates B cell development by targeting Sox4

Author(s): Mehta A, Mann M, Zhao JL, Marinov GK, Majumdar D, et al.

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma

Author(s): Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, et al.

MYC/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells

Author(s): Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M et al.